Decisions in Life Sciences

Trinity Life Sciences
  • 0.0 (0)
  • Management
  • Monthly

Join a panel of industry experts as they discuss the decisions being made in life sciences today, and the impact those decisions will have on the healthcare ecosystem tomorrow. Hit the subscribe button to stay up-to-date with the latest perspectives.

Episodes

  1. 28/11/2022

    What Leaders in Life Sciences Need to Know to be Prepared for 2023

    Download the Advisory Brief: ‘What You Need to Know to be Prepared for 2023: Highlights from TGaS Advisors’ Fall Summit’ to understand the data behind the insights delivered in this podcast: https://bit.ly/3g8btP7 ____________________ Host and President of TGaS Advisors, Gary McWalters, joins a panel of four experts from TGaS Advisors, a division of Trinity Life Sciences, to discuss the key themes that were discussed at the TGaS Fall Client Summit – an annual event that brings together leaders in life sciences to discuss innovative solutions to the common challenges faced within commercial operations. Expert Panel: Kim Woodhour | Field Operations Director Brian Voellmecke | Commercial Data Management Leader Jim Castello | Incentive Compensation Leader Ken McDermott | Executive Commercial Operations Leader Key Topics of Discussion: The evolution of the commercial model in life sciences Capabilities that organizations need to keep pace with change Identifying the right key performance metrics How leaders of life sciences should prepare for 2023 ____________________ Read Trinity Life Sciences’ advisory brief ‘What You Need to Know to be Prepared for 2023: Highlights from TGaS Advisors’ Fall Summit’ to understand the data behind the insights based on Trinity’s work with 2000+ biopharma executives across 300 partner companies, and the key themes that emerged during our onsite 2022 Fall Client Summit in Philadelphia.

    38 min

  2. 29/09/2022

    Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials

    Download the White Paper: Diversity in Clinical Trials Participation: A Life Sciences Perspective | https://bit.ly/3LQRFeq ____________________ The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants? Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject matter experts that authored Trinity Life Sciences’ cornerstone white paper to discuss why ensuring diversity in clinical trials participation is such a critical issue, the results of the team’s research, and the action-oriented recommendations that they have for the life sciences industry. Expert Panel: Michele Andrews | Principal, Strategic Advisory and Head of the Dynamic Market Intelligence Center of Excellence Monique Marsh | Associate Director of Primary Market Research and Head of the Qualitative Research Center of Excellence____________________ Download the White Paper: Read Trinity Life Sciences’ white paper ‘Diversity in Clinical Trials Participation: A Life Sciences Perspective’ to understand how you and your organization can help to further diversity in clinical trials. ____________________ Thank you to everyone who contributed towards this important research: Peter Palumbo, Patrick Hong, Monique Marsh, Shanice O’Brien, Courtney Poopat, Catherine Toal, Michele Andrews, Herman Sanchez, Sumudu Dehipawala, UT Yadav, Alexander Fish, Peter Baek, Alessandra Moscoso, Shruti Nambiar, and Justin Li

    13 min

  3. 11/08/2022

    Capitalizing on Opportunities to Drive Impact in Commercial Operations

    Download the Advisory Brief: Capitalizing on Opportunities to Drive Impact in Commercial Operations | https://bit.ly/3IFUZra _______________________________________ In the wake of the COVID-19 pandemic, pharmaceutical companies have needed to pivot in the way they operate so that they can keep information flowing to providers and patients. Commercial Operations functions have since been capitalizing on opportunities to enhance their capabilities and drive impact across their organizations. Host and Executive Commercial Operations Leader, Ken McDermott, joins a panel of three experts from TGaS Advisors, a division of Trinity Life Sciences, to discuss the shifting priorities as commercial teams work to evolve virtual and digital channels to engage with customers and sharpen advanced analytics. Expert Panel:  Lisa Klein | Vice President, Field OperationsJerry Luciano | Vice President, Digital and Omnichannel SolutionsSteve Laux | Vice President, Commercial Insights and Advanced Analytics SolutionsDownload the Advisory Brief: Read Trinity Life Sciences’ advisory brief 'Capitalizing on Opportunities to Drive Impact in Commercial Operations’to understand the data behind the insights based on Trinity’s work with 2000+ individuals across 300 partner companies, and the key themes that emerged during our 2022 Spring Virtual Client Summit.

    23 min
  • 3 Episodes

About

Join a panel of industry experts as they discuss the decisions being made in life sciences today, and the impact those decisions will have on the healthcare ecosystem tomorrow. Hit the subscribe button to stay up-to-date with the latest perspectives.

Information

  • Creator
    Trinity Life Sciences
  • Years Active
    2k
  • Episodes
    3
  • Rating
    Clean
  • Copyright
    © 2022 Decisions in Life Sciences
  • Show Website
    Decisions in Life Sciences